Key result
Hepatic steatosis, both alone and especially when combined with metabolic syndrome, was independently associated with significantly decreased LDL peak particle size compared to controls.
Why the study?
Does hepatic steatosis, alone or combined with metabolic syndrome, affect LDL particle size and carotid atherosclerosis in healthy workers?
Cross-Sectional (n=274)
No
Does hepatic steatosis, alone or combined with metabolic syndrome, affect LDL particle size and carotid atherosclerosis in healthy workers?
Absolute Event Rate: 26.8% vs 27.6%
p-value: p=<0.001
Hepatic steatosis, particularly when combined with metabolic syndrome, is independently associated with smaller, denser LDL particles and increased carotid intima-media thickness, indicating an elevated cardiovascular risk profile.
Should not yet change lipid assessment in practice; hypothesis-generating for hepatic steatosis as a driver of atherogenic LDL profiles.
BACKGROUND: Hepatic steatosis (HS), the most frequent liver disorder, was reported to be an independent predictor of cardiovascular disease. HS, if combined with the metabolic syndrome (MetS), might have a synergistic effect on low-density lipoprotein (LDL) particle size. METHODS: Carotid intima-media thickness (IMT) and plaque formation, and HS were diagnosed ultrasonographically, and the MetS was diagnosed using the ATP III criteria in 274 healthy workers (mean age +/- SD, 43.5 +/- 7.1 yrs). LDL particle size was measured with density gradient ultracentrifugation, and subfractions were classified as large, buoyant LDL I (27.2 to approximately 28.5 nm) and small, dense LDL III (24.2~25.5). All participants were grouped into three categories: control, subjects with HS alone and those with both HS and the MetS. RESULTS: The subjects with HS alone were 84 (30.7%), whereas those with HS and the MetS were 46 (16.8%). LDL peak particle sizes showed significant negative correlations with carotid mean IMTs. LDL peak particle size and LDL I (%) decreased significantly in the HS, showing the lowest values in the subjects with both HS and the MetS, and their association was independent, even adjusted for potential confounders. LDL III also showed independent associations across the groups. CONCLUSION: HS alone was more prevalent than HS combined with the MetS in general population. For the patients with HS alone, LDL particle size and carotid atherosclerosis were found to fall in the middle of the control and those with both HS and the MetS.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2010) conducted a cross-sectional in Hepatic steatosis and metabolic syndrome (n=274). Hepatic steatosis with or without metabolic syndrome vs. Control (no hepatic steatosis or metabolic syndrome) was evaluated on LDL peak particle size (nm) (p=<0.001). Hepatic steatosis, both alone and especially when combined with metabolic syndrome, was independently associated with significantly decreased LDL peak particle size compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: